Literature DB >> 24992522

Plasma volume expansion with 5% albumin compared to Ringer's acetate during normal and increased microvascular permeability in the rat.

Peter Bansch1, Svajunas Statkevicius, Peter Bentzer.   

Abstract

BACKGROUND: It is believed that the effectiveness of colloids as plasma volume expanders is dependent on the endothelial permeability for macromolecules. The objective of this study was to test the hypothesis that the plasma volume expanding effect of 5% albumin relative to that of a crystalloid solution is reduced if microvascular permeability is increased.
METHODS: A control group was resuscitated with either 5% albumin (8 ml/kg) or Ringer's acetate (36 ml/kg) immediately after a hemorrhage of 8 ml/kg (n = 29). In a second group, permeability was increased by inducing sepsis through cecal ligation and incision (n = 28). Three hours after cecal ligation and incision, the animals were resuscitated with either 5% albumin in a ratio of 1:1 relative to the volume of lost plasma, or Ringer's acetate in a ratio of 4.5:1.
RESULTS: In the hemorrhage group, plasma volumes at 15 min after resuscitation with albumin or Ringer's acetate had increased by 9.8 ± 2.6 ml/kg (mean ± SD) and 7.4 ± 2.9 ml/kg and were similar at 2 and 4 h. Plasma volume 3 h after cecal ligation and incision had decreased by approximately 7 ml/kg, and at 15 min after resuscitation with albumin or Ringer's acetate it had increased by 5.7 ± 2.9 and 2.4 ± 3.0 ml/kg, respectively (P < 0.05). At 2 and 4 h after resuscitation, plasma volumes did not differ between the groups.
CONCLUSION: This study does not support the hypothesis that the plasma-volume-expanding effect of albumin relative to that of crystalloids is decreased under conditions characterized by increased permeability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992522     DOI: 10.1097/ALN.0000000000000363

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Beyond the fluid bolus.

Authors:  Peter Bentzer; Anja Lindén-Søndersø
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  The use of pulse pressure variation for predicting impairment of microcirculatory blood flow.

Authors:  Christoph R Behem; Michael F Graessler; Till Friedheim; Rahel Kluttig; Hans O Pinnschmidt; Anna Duprée; E Sebastian Debus; Daniel A Reuter; Sabine H Wipper; Constantin J C Trepte
Journal:  Sci Rep       Date:  2021-04-28       Impact factor: 4.379

Review 3.  Role of albumin in the preservation of endothelial glycocalyx integrity and the microcirculation: a review.

Authors:  Cesar Aldecoa; Juan V Llau; Xavier Nuvials; Antonio Artigas
Journal:  Ann Intensive Care       Date:  2020-06-22       Impact factor: 6.925

4.  Normalization of blood clotting characteristics using prothrombin complex concentrate, fibrinogen and FXIII in an albumin based fluid: experimental studies in thromboelastometry.

Authors:  Tobias Koller; Nadia Kinast; Andres Guilarte Castellanos; Sergio Perez Garcia; Pilar Paniagua Iglesias; Xavi León Vintro; Jose Mateo Arranz; Noelia Vilalta Seto; Ma Victòria Moral García; Ana Belén Moreno-Castaño; Jose Aznar-Salatti; Gines Escolar Albaladejo; Maribel Diaz-Ricart
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-04-09       Impact factor: 2.953

Review 5.  Fluid Therapy and the Microcirculation in Health and Critical Illness.

Authors:  Edward S Cooper; Deborah C Silverstein
Journal:  Front Vet Sci       Date:  2021-05-13

6.  Effects of fresh frozen plasma, Ringer's acetate and albumin on plasma volume and on circulating glycocalyx components following haemorrhagic shock in rats.

Authors:  Axel Nelson; Svajunas Statkevicius; Ulf Schött; Pär I Johansson; Peter Bentzer
Journal:  Intensive Care Med Exp       Date:  2016-03-03

7.  Effect of ringers acetate in different doses on plasma volume in rat models of hypovolemia.

Authors:  Svajunas Statkevicius; Attila Frigyesi; Peter Bentzer
Journal:  Intensive Care Med Exp       Date:  2017-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.